Answers are grounded in this paper and cite their sources.
The paradigm of sexual differentiation holds that female embryos retain the Müllerian ducts, the precursor of the female reproductive tract, by default in the absence of anti-Müllerian hormone (AMH). However, whether Müllerian duct maintenance requires active signaling remains unknown. Here, using mouse genetic models, we discover that deletion of mesenchymal Gata2 causes selective regression of the cranial Müllerian duct, the precursor of the oviduct. This regression is not driven by ectopic AMH signaling but may instead result from the loss of region-specific NRG1 signaling. Deletion of mesenchymal Gata2 also causes uterine hypoplasia and vaginal atresia, whereas epithelial Gata2 is specifically required for uterine gland differentiation. These genetic mouse studies reveal a Gata2 -dependent, region-specific program that actively maintains the Müllerian duct and promotes female reproductive tract differentiation. Extending these findings to humans, we report two individuals with GATA2 deficiency who exhibit utero-vaginal agenesis or hypoplasia, consistent with Mayer-Rokitansky-Küster-Hauser syndrome. Collectively, our results identify Gata2 / GATA2 as a critical regulator of Müllerian duct development, providing new insights into the molecular mechanisms underlying female reproductive tract development and Müllerian anomalies.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: